The emerging duck flavivirus is not pathogenic for primates and is highly sensitive to mammalian interferon antiviral signaling

Journal of Virology

Volumn 90, Issue 14, 2016, Pages 6538-6548

  Wang, Hong Jiang ^a   Li, Xiao Feng ^a   Liu, Long ^a,b   Xu, Yan Peng ^a   Ye, Qing ^a   Deng, Yong Qiang ^a   Huang, Xing Yao ^a   Zhao, Hui ^a   Qin, E De ^a   Shi, Pei Yong ^c   Gao, George F ^d,e   Qina, Cheng Feng ^a,b  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c University of Texas Medical Branch School of Medicine   (United States)

^d INSTITUTE OF MICROBIOLOGY   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON RECEPTOR; ANTIVIRUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCK TEMBUSU VIRUS; FEMALE; FLAVIVIRUS; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; INFECTION RISK; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIGNAL TRANSDUCTION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS VIRULENCE; A-549 CELL LINE; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CHLOROCEBUS AETHIOPS; COMPARATIVE STUDY; DRUG EFFECTS; DUCK; FLAVIVIRUS INFECTIONS; HELA CELL LINE; HEP-G2 CELL LINE; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOGENICITY; PHYSIOLOGY; POULTRY DISEASES; VERO CELL LINE; VIROLOGY;

A549 CELLS; ANIMALS; ANTIVIRAL AGENTS; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DUCKS; FEMALE; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HELA CELLS; HEP G2 CELLS; HUMANS; INTERFERON TYPE I; MACACA MULATTA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; POULTRY DISEASES; RECEPTORS, INTERFERON; VERO CELLS;

EID: 84977479476     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00197-16     Document Type: Article

References (48)

1. Bolling BG, Weaver SC, Tesh RB, Vasilakis N. 2015. Insect-specific virus discovery: significance for the arbovirus community. Viruses 7:4911-4928 http://dx.doi.org/10.3390/v7092851.
2. Liu P, Lu H, Li S, Moureau G, Deng YQ, Wang Y, Zhang L, Jiang T, de Lamballerie X, Qin CF, Gould EA, Su J, Gao GF. 2012. Genomic and antigenic characterization of the newly emerging Chinese duck egg-drop syndrome flavivirus: genomic comparison with Tembusu and Sitiawan viruses. J Gen Virol 93:2158 -2170. http://dx.doi.org/10.1099/vir.0 .043554-0.
3. Burke CW, Mason JN, Surman SL, Jones BG, Dalloneau E, Hurwitz JL, Russell CJ. 2011. Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy. PLoS Pathog 7:e1002134. http://dx.doi.org/10.1371/journal.ppat.1002134.
4. Homonnay ZG, Kovacs EW, Banyai K, Albert M, Feher E, Mato T, Tatar-Kis T, Palya V. 2014. Tembusu-like flavivirus (Perak virus) as the cause of neurological disease outbreaks in young Pekin ducks. Avian Pathol 43:552-560. http://dx.doi.org/10.1080/03079457.2014.973832.
5. Thontiravong A, Ninvilai P, Tunterak W, Nonthabenjawan N, Chaiyavong S, Angkabkingkaew K, Mungkundar C, Phuengpho W, Oraveerakul K, Amonsin A. 2015. Tembusu-related flavivirus in ducks, Thailand. Emerg Infect Dis 21:2164-2167. http://dx.doi.org/10.3201 /eid2112.150600.
6. Wan C, Huang Y, Fu G, Shi S, Cheng L, Chen H. 2012. Complete genome sequence of avian Tembusu-related virus strainWRisolated from White Kaiya ducks in Fujian, China. J Virol 86:10912. http://dx.doi.org/10 .1128/JVI.01582-12.
7. Wang Y, Yuan X, Li Y, Yu K, Yang J, Xu H, Zhang Y, Liao M, Qin Z. 2011. Rapid detection of newly isolated Tembusu-related flavivirus by reverse-transcription loop-mediated isothermal amplification assay. Virol J 8:553. http://dx.doi.org/10.1186/1743-422X-8-553.
8. Yan L, Yan P, Zhou J, Teng Q, Li Z. 2011. Establishing a TaqMan-based real-time PCR assay for the rapid detection and quantification of the newly emerged duck Tembusu virus. Virol J 8:464. http://dx.doi.org/10 .1186/1743-422X-8-464.
9. Yan P, Zhao Y, Zhang X, Xu D, Dai X, Teng Q, Yan L, Zhou J, Ji X, Zhang S, Liu G, Zhou Y, Kawaoka Y, Tong G, Li Z. 2011. An infectious disease of ducks caused by a newly emerged Tembusu virus strain in mainland China. Virology 417:1-8. http://dx.doi.org/10.1016/j.virol.2011.06 .003.
10. Chen S, Wang S, Li Z, Lin F, Cheng X, Zhu X, Wang J, Chen S, Huang M, Zheng M. 2014. Isolation and characterization of a Chinese strain of Tembusu virus from Hy-Line Brown layers with acute egg-drop syndrome in Fujian, China. Arch Virol 159:1099-1107. http://dx.doi.org/10.1007 /s00705-013-1931-0.
11. Huang X, Han K, Zhao D, Liu Y, Zhang J, Niu H, Zhang K, Zhu J, Wu D, Gao L, Li Y. 2013. Identification and molecular characterization of a novel flavivirus isolated from geese in China. Res Vet Sci 94:774-780. http://dx.doi.org/10.1016/j.rvsc.2012.11.014.
12. Liu M, Chen S, Chen Y, Liu C, Chen S, Yin X, Li G, Zhang Y. 2012. Adapted Tembusu-like virus in chickens and geese in China. J Clin Microbiol 50:2807-2809. http://dx.doi.org/10.1128/JCM.00655-12.
13. Tang Y, Diao Y, Chen H, Ou Q, Liu X, Gao X, Yu C, Wang L. 2015. Isolation and genetic characterization of a Tembusu virus strain isolated from mosquitoes in Shandong, China. Transbound Emerg Dis 62:209-216. http://dx.doi.org/10.1111/tbed.12111.
14. Li X, Shi Y, Liu Q, Wang Y, Li G, Teng Q, Zhang Y, Liu S, Li Z. 2015. Airborne transmission of a novel Tembusu virus in ducks. J Clin Microbiol 53:2734-2736. http://dx.doi.org/10.1128/JCM.00770-15.
15. Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, Foster GR, Jacobs M. 2005. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 79:5414-5420. http://dx.doi.org/10 .1128/JVI.79.9.5414-5420.2005.
16. Laurent-Rolle M, Morrison J, Rajsbaum R, Macleod JM, Pisanelli G, Pham A, Ayllon J, Miorin L, Martinez-Romero C, tenOever BR, Garcia-Sastre A. 2014. The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon. Cell Host Microbe 16:314-327. http://dx.doi.org/10.1016/j.chom.2014.07.015.
17. Ashour J, Laurent-Rolle M, Shi PY, Garcia-Sastre A. 2009. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83:5408-5418. http://dx.doi.org/10.1128/JVI.02188-08.
18. Laurent-Rolle M, Boer EF, Lubick KJ, Wolfinbarger JB, Carmody AB, Rockx B, Liu W, Ashour J, Shupert WL, Holbrook MR, Barrett AD, Mason PW, Bloom ME, Garcia-Sastre A, Khromykh AA, Best SM. 2010. The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol 84: 3503-3515. http://dx.doi.org/10.1128/JVI.01161-09.
19. Lin RJ, Chang BL, Yu HP, Liao CL, Lin YL. 2006. Blocking of interferoninduced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol 80:5908 -5918. http://dx.doi.org/10.1128/JVI.02714-05.
20. Yun T, Zhang D, Ma X, Cao Z, Chen L, Ni Z, Ye W, Yu B, Hua J, Zhang Y, Zhang C. 2012. Complete genome sequence of a novel flavivirus, duck Tembusu virus, isolated from ducks and geese in china. J Virol 86:3406-3407. http://dx.doi.org/10.1128/JVI.07132-11.
21. Tang Y, Gao X, Diao Y, Feng Q, Chen H, Liu X, Ge P, Yu C. 2013. Tembusu virus in human, China. Transbound Emerg Dis 60:193-196. http://dx.doi.org/10.1111/tbed.12085.
22. The Royal Society. 2005. The Weatherall report on the use of non-human primates. The Royal Society, London, United Kingdom.
23. Ye Q, Li XF, Zhao H, Li SH, Deng YQ, Cao RY, Song KY, Wang HJ, Hua RH, Yu YX, Zhou X, Qin ED, Qin CF. 2012. A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1= formation and contributes to attenuation. J Gen Virol 93: 1959-1964. http://dx.doi.org/10.1099/vir.0.043844-0.
24. Li XF, Deng YQ, Yang HQ, Zhao H, Jiang T, Yu XD, Li SH, Ye Q, Zhu SY, Wang HJ, Zhang Y, Ma J, Yu YX, Liu ZY, Li YH, Qin ED, Shi PY, Qin CF. 2013. A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates. J Virol 87:13694-13705. http://dx.doi.org/10.1128/JVI.00931-13.
25. Rumyantsev AA, Goncalvez AP, Giel-Moloney M, Catalan J, Liu Y, Gao QS, Almond J, Kleanthous H, Pugachev KV. 2013. Single-dose vaccine against tick-borne encephalitis. Proc Natl Acad Sci U S A 110:13103-13108. http://dx.doi.org/10.1073/pnas.1306245110.
26. Reed LJ, Muench H. 1938. A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497.
27. Blitvich BJ, Firth AE. 2015. Insect-specific flaviviruses: a systematic review of their discovery, host range, mode of transmission, superinfection exclusion potential and genomic organization. Viruses 7:1927-1959. http: //dx.doi.org/10.3390/v7041927.
28. Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, Harris E. 2000. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74:4957-4966. http://dx.doi.org/10.1128/JVI .74.11.4957-4966.2000.
29. Holbrook MR, Aronson JF, Campbell GA, Jones S, Feldmann H, Barrett AD. 2005. An animal model for the tickborne flavivirus-Omsk hemorrhagic fever virus. J Infect Dis 191:100-108. http://dx.doi.org/10 .1086/426397.
30. Meier KC, Gardner CL, Khoretonenko MV, Klimstra WB, Ryman KD. A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog 5:e1000614. http://dx.doi.org/10.1371 /journal.ppat.1000614.
31. Zellweger RM, Shresta S. 2014. Mouse models to study dengue virus immunology and pathogenesis. Front Immunol 5:151. http://dx.doi.org /10.3389/fimmu.2014.00151.
32. Pletnev AG, Putnak R, Speicher J, Wagar EJ, Vaughn DW. 2002. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc Natl Acad Sci U S A 99:3036-3041. http://dx.doi.org/10 .1073/pnas.022652799.
33. Song BH, Yun GN, Kim JK, Yun SI, Lee YM. 2012. Biological and genetic properties of SA(1)(4)-14-2, a live-attenuated Japanese encephalitis vaccine that is currently available for humans. J Microbiol 50:698-706. http://dx.doi.org/10.1007/s12275-012-2336-6.
34. Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrett AD, Monath TP. 1999. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology 257:363-372. http://dx.doi.org/10.1006/viro .1999.9695.
35. Pletnev AG, Men R. 1998. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4. Proc Natl Acad Sci U S A 95:1746-1751. http://dx.doi.org/10.1073/pnas.95.4.1746.
36. Levy O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7:379 -390. http://dx.doi.org/10 .1038/nri2075.
37. Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Despres P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M. 2008. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 4:e29. http://dx.doi .org/10.1371/journal.ppat.0040029.
38. Ryman KD, Klimstra WB, Nguyen KB, Biron CA, Johnston RE. 2000. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol 74:3366 -3378. http://dx.doi.org/10.1128/JVI.74.7.3366 -3378.2000.
39. Taylor KG, Woods TA, Winkler CW, Carmody AB, Peterson KE. 2014. Age-dependent myeloid dendritic cell responses mediate resistance to La Crosse virus-induced neurological disease. J Virol 88:11070-11079. http: //dx.doi.org/10.1128/JVI.01866-14.
40. Ratterree MS, Gutierrez RA, Travassos da Rosa AP, Dille BJ, Beasley DW, Bohm RP, Desai SM, Didier PJ, Bikenmeyer LG, Dawson GJ, Leary TP, Schochetman G, Phillippi-Falkenstein K, Arroyo J, Barrett AD, Tesh RB. 2004. Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection. J Infect Dis 189:669-676. http://dx.doi.org/10 .1086/381461.
41. Dean CH, Alarcon JB, Waterston AM, Draper K, Early R, Guirakhoo F, Monath TP, Mikszta JA. 2005. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates.HumVaccin 1:106-111. http://dx.doi.org/10.4161/hv .1.3.1797.
42. Pletnev AG, Bray M, Hanley KA, Speicher J, Elkins R. 2001. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes. J Virol 75:8259-8267. http://dx.doi.org/10.1128/JVI.75.17 .8259-8267.2001.
43. Guirakhoo F, Weltzin R, Chambers TJ, Zhang ZX, Soike K, Ratterree M, Arroyo J, Georgakopoulos K, Catalan J, Monath TP. 2000. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol 74:5477-5485. http://dx.doi.org /10.1128/JVI.74.12.5477-5485.2000.
44. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A. 2000. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181:2-9. http: //dx.doi.org/10.1086/315215.
45. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL. 2002. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 186:1165-1168. http://dx.doi.org/10.1086 /343813.
46. Chambers TJ, Diamond MS. 2003. Pathogenesis of flavivirus encephalitis. Adv Virus Res 60:273-342. http://dx.doi.org/10.1016/S0065-3527 (03)60008-4.
47. Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, Park GS, Boer E, Wolfinbarger JB, Bloom ME. 2005. Inhibition of interferonstimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 79:12828-12839. http://dx .doi.org/10.1128/JVI.79.20.12828-12839.2005.
48. Ashraf U, Ye J, Ruan X, Wan S, Zhu B, Cao S. 2015. Usutu virus: an emerging flavivirus in Europe. Viruses 7:219-238. http://dx.doi.org/10 .3390/v7010219.